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↑What is “already known” in this topic: 
Lipid profiles are infrequently measured in clinical management of 
sepsis patients. The majority of previous studies focused on the 
comparative analysis of mean values of serum lipids between survivor 
and nonsurvivor groups or between sepsis and severe sepsis groups.   
 
→What this article adds: 
In this study, serum lipid levels were analysed over time and the 
association between lipid levels and survival in patients with sepsis 
was examined. The prevalence of hypocholesterolemia in sepsis 
patients was significantly higher than in the general population. 
However, absolute STC, LDL, HDL, and TG levels at the time of 
admission was not suitable to predict mortality in sepsis patients. The 
data of this study support the hypothesis that higher decline of serum 
total cholesterol and other lipid profile during hospital stay are 
associated with a higher mortality in sepsis patients. Thus, the 
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Abstract 
    Background: Lipid profiles are infrequently measured in clinical management of sepsis patients. Sepsis leads to significant 
alterations in the metabolism of lipids. The aim of the present study was to determine whether changes in plasma lipid concentrations 
during sepsis treatment were associated with clinical outcome.  
   Methods: In this study, 74 adult septic patients were included in this prospective observational study from January to December 
2017. Patients taking lipid lowering agents were excluded. A detailed medical history was obtained and clinical examination was 
performed. Serum total cholesterol (STC) and its fractions [low-and high-density lipoprotein] and triglyceride levels were measured in 
the morning of the first day after admission and then once weekly. The primary outcomes of the study were in-hospital mortality, and 
hospital stay and hypocholesterolemia were defined as STC levels < 50 mg/dL. Manne-Whitney U and chi-squared tests were used for 
data analysis, and significance level was set at p<0.05.  
   Results: In this study, 78.4% (CI 95%: 67.3-87.1) of patients had hypocholesterolemia. During the study period, 21.6% (CI 95%: 
12.9- 32.7) of patients died. All lipid (except TG) concentrations continuously decreased in deceased sepsis patients but increased in 
recovering patient (p value for STC (p=0.004), LDL (p=0.006), HDL (p=0.010), and TG (p=0.052)). The serum lipids concentration 
was not associated with length of hospital stay (p value for STC (p=0.524), LDL (p=0.813), HDL (p=0.799) and TG (p=0.581)).  
   Conclusion: In this study it was found that the additional decline of lipid profile was significantly associated with increased 
mortality rate of sepsis patients. Thus, the clinically termed 'the lipaemia of sepsis' is not true in all situations. 
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Sepsis is a frequent cause of admission and a frequent 
fatal condition characterized by a dysregulated inflamma-
tory response to microbial infection and altered metabolic 
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